Unlocking Youth: Award-Winning Innovation in Retinol Activation

The awarded paper, “Boosting Retinol Activity Using Novel Lecithin: Retinol Acyltransferase Inhibitors,” introduces a breakthrough strategy to enhance the anti-aging efficacy of retinol by targeting the LRAT enzyme pathway.

This pioneering research was conducted by a team of distinguished scientists: Dominik Imfeld, PhD; André Fischer, PhD; Rolf Schütz, PhD; Leithe Budel, PhD; and Professor Anthony Rawlings.

“At dsm-firmenich, we are proud global leaders on skincare vitamins. Our recent Vitamin A discoveries offer a promising way to enhance natural retinol in human skin, potentially leading to new anti-aging ingredients for cosmetic applications,” stated Dominik Imfeld, PhD, Associate Principal Scientist Skincare Global at dsm-firmenich.

In addition, Eve Chen, Application Laboratory Manager B&C in China, has been honoured with the Outstanding Individual Award for her contributions as an Efficacy Evaluation Expert.

This recognition underscores dsm-firmenich continued commitment to advancing scientific excellence and shaping the future of skin longevity innovation.

About dsm-firmenich

As innovators in nutrition, health, and beauty, dsm-firmenich reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world’s growing population to thrive. With our comprehensive range of solutions, with natural and renewable ingredients and renowned science and technology capabilities, we work to create what is essential for life, desirable for consumers, and more sustainable for the planet. dsm-firmenich is a Swiss company with dual headquarters in Kaiseraugst, Switzerland and Maastricht, Netherlands, listed on the Euronext Amsterdam, with operations in almost 60 countries and revenues of more than €12 billion. With a diverse, worldwide team of nearly 30,000 employees, we bring progress to life every day, everywhere, for billions of people. 
www.dsm-firmenich.com